177 related articles for article (PubMed ID: 20705485)
1. Transcriptional regulation of heart valve development and disease.
Wirrig EE; Yutzey KE
Cardiovasc Pathol; 2011; 20(3):162-7. PubMed ID: 20705485
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves.
Wirrig EE; Hinton RB; Yutzey KE
J Mol Cell Cardiol; 2011 Mar; 50(3):561-9. PubMed ID: 21163264
[TBL] [Abstract][Full Text] [Related]
3. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
[TBL] [Abstract][Full Text] [Related]
4. Conserved transcriptional regulatory mechanisms in aortic valve development and disease.
Wirrig EE; Yutzey KE
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):737-41. PubMed ID: 24665126
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves.
Sung DC; Bowen CJ; Vaidya KA; Zhou J; Chapurin N; Recknagel A; Zhou B; Chen J; Kotlikoff M; Butcher JT
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1627-37. PubMed ID: 27312222
[TBL] [Abstract][Full Text] [Related]
6. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
7. Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.
Rajamannan NM
Cardiovasc Pathol; 2011; 20(3):168-76. PubMed ID: 21257323
[TBL] [Abstract][Full Text] [Related]
8. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.
Bosse K; Hans CP; Zhao N; Koenig SN; Huang N; Guggilam A; LaHaye S; Tao G; Lucchesi PA; Lincoln J; Lilly B; Garg V
J Mol Cell Cardiol; 2013 Jul; 60():27-35. PubMed ID: 23583836
[TBL] [Abstract][Full Text] [Related]
9. Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties.
Bogdanova M; Zabirnyk A; Malashicheva A; Enayati KZ; Karlsen TA; Kaljusto ML; Kvitting JP; Dissen E; Sullivan GJ; Kostareva A; Stensløkken KO; Rutkovskiy A; Vaage J
Sci Rep; 2019 Sep; 9(1):12934. PubMed ID: 31506459
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammation: A key role in degeneration of bicuspid aortic valve.
Manno G; Bentivegna R; Morreale P; Nobile D; Santangelo A; Novo S; Novo G
J Mol Cell Cardiol; 2019 May; 130():59-64. PubMed ID: 30885747
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanisms for osteogenic differentiation of human aortic valve interstitial cells.
Wang Y; Xiao X; Zhou T; Han D; Dong N
J Thorac Cardiovasc Surg; 2020 May; 159(5):1742-1753.e7. PubMed ID: 31301902
[TBL] [Abstract][Full Text] [Related]
12. A Notch more: Molecular players in bicuspid aortic valve disease.
Lee A; Wei S; Schwertani A
J Mol Cell Cardiol; 2019 Sep; 134():62-68. PubMed ID: 31150732
[TBL] [Abstract][Full Text] [Related]
13. Developmental origins for semilunar valve stenosis identified in mice harboring congenital heart disease-associated
LaHaye S; Majumdar U; Yasuhara J; Koenig SN; Matos-Nieves A; Kumar R; Garg V
Dis Model Mech; 2019 Jun; 12(6):. PubMed ID: 31138536
[TBL] [Abstract][Full Text] [Related]
14. GATA6 Regulates Aortic Valve Remodeling, and Its Haploinsufficiency Leads to Right-Left Type Bicuspid Aortic Valve.
Gharibeh L; Komati H; Bossé Y; Boodhwani M; Heydarpour M; Fortier M; Hassanzadeh R; Ngu J; Mathieu P; Body S; Nemer M;
Circulation; 2018 Sep; 138(10):1025-1038. PubMed ID: 29567669
[TBL] [Abstract][Full Text] [Related]
15. Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves.
Nigam V; Sievers HH; Jensen BC; Sier HA; Simpson PC; Srivastava D; Mohamed SA
J Heart Valve Dis; 2010 Jul; 19(4):459-65. PubMed ID: 20845893
[TBL] [Abstract][Full Text] [Related]
16. TLR4 Stimulation Promotes Human AVIC Fibrogenic Activity through Upregulation of Neurotrophin 3 Production.
Yao Q; The E; Ao L; Zhai Y; Osterholt MK; Fullerton DA; Meng X
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074942
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-138 Suppresses Osteoblastic Differentiation of Valvular Interstitial Cells in Degenerative Calcific Aortic Valve Disease.
Lu P; Yin B; Liu L
Int Heart J; 2019 Jan; 60(1):136-144. PubMed ID: 30464116
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling.
Toshima T; Watanabe T; Narumi T; Otaki Y; Shishido T; Aono T; Goto J; Watanabe K; Sugai T; Takahashi T; Yokoyama M; Kinoshita D; Tamura H; Kato S; Nishiyama S; Arimoto T; Takahashi H; Miyamoto T; Sadahiro M; Watanabe M
Cardiovasc Res; 2020 Apr; 116(5):983-994. PubMed ID: 31393559
[TBL] [Abstract][Full Text] [Related]
19. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
Gee T; Farrar E; Wang Y; Wu B; Hsu K; Zhou B; Butcher J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):638-655. PubMed ID: 31893948
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells.
Choi B; Lee S; Kim SM; Lee EJ; Lee SR; Kim DH; Jang JY; Kang SW; Lee KU; Chang EJ; Song JK
Circulation; 2017 May; 135(20):1935-1950. PubMed ID: 28179397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
